Literature DB >> 10890542

Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis.

K Buttenschoen1, D Berger, N Hiki, D C Buttenschoen, C Vasilescu, F Chikh-Torab, M Seidelmann, H G Beger.   

Abstract

OBJECTIVE: To elucidate the time course of endotoxaemia and antiendotoxin antibodies in patients with acute pancreatitis.
DESIGN: Prospective clinical study.
SETTING: University hospital, Germany.
SUBJECTS: 25 patients with oedematous (n = 9) or necrotising (n = 16) pancreatitis, and 20 healthy controls. MAIN OUTCOME MEASURES: Concentrations of endotoxin and immunoglobulins (classes G, M, and A) directed at two lipid A molecules, four lipopolysaccharides, and alpha-haemolysin of Staphylococcus aureus measurements in plasma during a 12 day period.
RESULTS: There were no differences in the degree of endotoxaemia between patients with oedematous and necrotising pancreatitis on admission. However, from the day after admission and throughout the observation period patients with necrotising pancreatitis had significantly higher concentrations of endotoxin than those with oedematous pancreatitis. Concentrations of IgM specific for endotoxin peaked at day 4, and then decreased in patients with oedematous pancreatitis while remaining high for those with necrotising pancreatitis. There was only a slight increase in IgA specific for endotoxin, and IgG and immunoglobulins to gamma-haemolysin remained steady throughout the observation period. There was strong cross-reactivity (r > 0.7) between IgM specific for endotoxin (70%), but this was less with IgA (52%), and IgG (20%).
CONCLUSIONS: Necrotising pancreatitis is accompanied by persistent endotoxaemia with an extended rise in antiendotoxin antibodies. Patients with oedematous pancreatitis have a transient endotoxaemia with a temporary increase of Ig specific for endotoxin. Endotoxin stimulates the synthesis of specific antibodies (IgM) despite general immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10890542     DOI: 10.1080/110241500750008772

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  7 in total

1.  Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis.

Authors:  Bettina Rau; Gerald Steinbach; Colin M Krüger; Katja Baumgart; Martin Schilling; Hans G Beger
Journal:  Langenbecks Arch Surg       Date:  2003-07-11       Impact factor: 3.445

2.  Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis.

Authors:  Sakhawat H Rahman; Basil J Ammori; John Holmfield; Michael Larvin; Michael J McMahon
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

3.  Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response?

Authors:  S H Rahman; B J Ammori; M Larvin; M J McMahon
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

4.  Endotoxemia and endotoxin tolerance in patients with ARDS.

Authors:  Klaus Buttenschoen; Marko Kornmann; Dieter Berger; Gerhard Leder; Hans G Beger; Catalin Vasilescu
Journal:  Langenbecks Arch Surg       Date:  2008-03-05       Impact factor: 3.445

5.  Relationship between overexpression of NK-1R, NK-2R and intestinal mucosal damage in acute necrotizing pancreatitis.

Authors:  Xin Shi; Nai-Rong Gao; Qing-Ming Guo; Yong-Jiu Yang; Ming-Dong Huo; Hao-Lin Hu; Helmut Friess
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

6.  Association of endotoxaemia & gut permeability with complications of acute pancreatitis: Secondary analysis of data.

Authors:  Namrata Singh; Ujjwal Sonika; Praneeth Moka; Brij Sharma; Vikas Sachdev; Sushil Kumar Mishra; Ashish Datt Upadhyay; Anoop Saraya
Journal:  Indian J Med Res       Date:  2019-06       Impact factor: 2.375

Review 7.  Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury - A Narrative Review.

Authors:  YaLan Luo; ZhaoXia Li; Peng Ge; HaoYa Guo; Lei Li; GuiXin Zhang; CaiMing Xu; HaiLong Chen
Journal:  J Inflamm Res       Date:  2021-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.